These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 3425599)
21. Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations. Kolodny EH; Firon N; Eyal N; Horowitz M Am J Med Genet; 1990 Aug; 36(4):467-72. PubMed ID: 2117855 [TBL] [Abstract][Full Text] [Related]
22. Homozygote and heterozygote identification. Wenger DA; Roth S Prog Clin Biol Res; 1982; 95():551-72. PubMed ID: 6812086 [No Abstract] [Full Text] [Related]
23. 4-Trifluoromethylumbelliferyl glycosides as new substrates for revealing diseases connected with hereditary deficiency of lysosome glycosidases. Karpova EA; Voznyi YaV ; Dudukina TV; Tsvetkova IV Biochem Int; 1991 Aug; 24(6):1135-44. PubMed ID: 1781792 [TBL] [Abstract][Full Text] [Related]
24. Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate. Grabowski GA; Dinur T; Gatt S; Desnick RJ Clin Chim Acta; 1982 Sep; 124(1):123-35. PubMed ID: 6889929 [TBL] [Abstract][Full Text] [Related]
25. An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside. Barns RJ; Clague AE Clin Chim Acta; 1982 Mar; 120(1):57-63. PubMed ID: 7067140 [TBL] [Abstract][Full Text] [Related]
27. Glucocerebroside storage in normal monocyte cultures. Hardy B; Teitelman-Weissman B; Chazan S; Neri A Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254 [TBL] [Abstract][Full Text] [Related]
28. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers. Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637 [TBL] [Abstract][Full Text] [Related]
29. Carriers and patients with muscle-eye-brain disease can be rapidly diagnosed by enzymatic analysis of fibroblasts and lymphoblasts. Vajsar J; Zhang W; Dobyns WB; Biggar D; Holden KR; Hawkins C; Ray P; Olney AH; Burson CM; Srivastava AK; Schachter H Neuromuscul Disord; 2006 Feb; 16(2):132-6. PubMed ID: 16427280 [TBL] [Abstract][Full Text] [Related]
30. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease. Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474 [TBL] [Abstract][Full Text] [Related]
32. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation]. Hou L; Kousaku O Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188 [TBL] [Abstract][Full Text] [Related]
33. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. Beutler E; Kuhl W J Lab Clin Med; 1970 Nov; 76(5):747-55. PubMed ID: 5477334 [No Abstract] [Full Text] [Related]
34. Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening. Nakagawa S; Kumin S; Sachs G; Nitowsky HM Am J Med Genet; 1983 Mar; 14(3):525-32. PubMed ID: 6859103 [TBL] [Abstract][Full Text] [Related]
35. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes. Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009 [TBL] [Abstract][Full Text] [Related]
36. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation). Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752 [TBL] [Abstract][Full Text] [Related]
37. [Heterogeneity of inborn glycolipidoses and glycoproteinoses and their enzymologic diagnosis]. Tsvetkova IV Vopr Med Khim; 1982; 28(3):32-41. PubMed ID: 6808764 [No Abstract] [Full Text] [Related]
38. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside. Broadhead DM; Butterworth J Clin Chim Acta; 1977 Feb; 75(1):155-61. PubMed ID: 14796 [TBL] [Abstract][Full Text] [Related]
39. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage. Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396 [TBL] [Abstract][Full Text] [Related]
40. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations. Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]